Key Takeaways
- • CVC Capital is in active restructuring discussions with lenders regarding a $350 million acquisition loan used to fund its 2021 leveraged buyout of specialty chemicals company Sajjan India, representing CVC's largest deal in the Indian market at Rs 7,000 crore valuation.
- • Sajjan India's financial performance has deteriorated sharply, with FY24 revenue declining 30 percent to Rs 1,052 crore and net profit collapsing 61 percent to Rs 106 crore, creating cash flow pressure that threatens the company's ability to service or refinance debt obligations.
- • The company's valuation has compressed significantly since CVC's majority stake acquisition; a recent 10 percent stake buyback from a former promoter valued the company at approximately Rs 2,190 crore in FY25, representing a 69 percent valuation decline from the original deal.
- • The debt restructuring request reflects broader cash flow constraints stemming from operational headwinds affecting both topline revenue and profitability, compressing margins across the specialty chemicals business.
Summary
CVC Capital is negotiating with lenders to restructure approximately $350 million in debt financing that supported its 2021 leveraged buyout of specialty chemicals manufacturer Sajjan India. The restructuring effort comes against a backdrop of significant operational deterioration at the acquired company, which has faced mounting business pressures that have substantially eroded its financial performance and cash generation capacity.
CVC acquired an 89 percent controlling stake in Sajjan India at a valuation of Rs 7,000 crore, marking the private equity firm's largest investment in the Indian market. The acquisition was structured as a leveraged buyout, a standard PE transaction model in which debt financing is deployed alongside equity to enhance overall returns on the investment. However, the company's subsequent underperformance has created refinancing challenges, forcing CVC to seek modified loan terms with its lending syndicate.
Financial deterioration at Sajjan India has been pronounced. In FY24, the company's revenue contracted 30 percent to Rs 1,052 crore from the prior year, while net profit declined even more steeply—falling approximately 61 percent to Rs 106 crore. Beyond these headline figures, the company faces margin compression and weakened cash flow generation, directly impairing its capacity to meet debt service obligations or refinance maturing facilities on original terms. According to sources familiar with the matter, "the company's business is under pressure and its topline and bottomline have fallen significantly from the past financial years. This has put pressure on its ability to generate cash flows to make debt repayments or refinance the loans."
The valuation impairment is substantial. In FY25, Sajjan India repurchased a 10 percent stake from a former promoter for Rs 219 crore, implying an enterprise valuation of Rs 2,190 crore—a decline of approximately 69 percent from CVC's original acquisition valuation just four years prior. This valuation compression underscores the severity of the operational and market headwinds affecting the specialty chemicals business.
CVC acquired an 89 percent controlling stake in Sajjan India at a valuation of Rs 7,000 crore, marking the private equity firm's largest investment in the Indian market. The acquisition was structured as a leveraged buyout, a standard PE transaction model in which debt financing is deployed alongside equity to enhance overall returns on the investment. However, the company's subsequent underperformance has created refinancing challenges, forcing CVC to seek modified loan terms with its lending syndicate.
Financial deterioration at Sajjan India has been pronounced. In FY24, the company's revenue contracted 30 percent to Rs 1,052 crore from the prior year, while net profit declined even more steeply—falling approximately 61 percent to Rs 106 crore. Beyond these headline figures, the company faces margin compression and weakened cash flow generation, directly impairing its capacity to meet debt service obligations or refinance maturing facilities on original terms. According to sources familiar with the matter, "the company's business is under pressure and its topline and bottomline have fallen significantly from the past financial years. This has put pressure on its ability to generate cash flows to make debt repayments or refinance the loans."
The valuation impairment is substantial. In FY25, Sajjan India repurchased a 10 percent stake from a former promoter for Rs 219 crore, implying an enterprise valuation of Rs 2,190 crore—a decline of approximately 69 percent from CVC's original acquisition valuation just four years prior. This valuation compression underscores the severity of the operational and market headwinds affecting the specialty chemicals business.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.